Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DTHIB robustly inhibits the HSF1 cancer gene signature and prostate cancer cell proliferation.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 31.00 | |
2 mg | In stock | $ 44.00 | |
5 mg | In stock | $ 72.00 | |
10 mg | In stock | $ 122.00 | |
25 mg | In stock | $ 255.00 | |
50 mg | In stock | $ 413.00 | |
100 mg | In stock | $ 596.00 | |
500 mg | In stock | $ 1,280.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 79.00 |
Description | DTHIB robustly inhibits the HSF1 cancer gene signature and prostate cancer cell proliferation. |
Targets&IC50 | DTHIB binding to the HSF1 DNA binding domain:160 nM (Kd) |
Molecular Weight | 309.68 |
Formula | C13H9ClFN3O3 |
CAS No. | 897326-30-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 25 mg/mL (80.73 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
DTHIB 897326-30-6 Cytoskeletal Signaling Metabolism HSP degradation HSP27 Inhibitor inhibit HSP70 HSF1 HSP90 cancer nuclear anticancer Heat shock proteins prostate inhibitor